Prenylamine inhibition of adriamycin-induced cardiomyopathy in mice.
Milei
J
J
Bolomo
N J
NJ
Marantz
A
A
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000009:adverse effects / Q000037:antagonists & inhibitors*; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D009202:Cardiomyopathies / Q000139:chemically induced / Q000473:pathology / Q000517:prevention & control*; D004305:Dose-Response Relationship, Drug; D004317:Doxorubicin / Q000009:adverse effects / Q000037:antagonists & inhibitors*; D005260:Female; D008297:Male; D051379:Mice; D011299:Prenylamine / Q000627:therapeutic use*; D011897:Random Allocation
D000903:Antibiotics, Antineoplastic; D002121:Calcium Channel Blockers; D004317:Doxorubicin; D011299:Prenylamine